These awards, totaling $800k over 2 years, will drive the intial development of the Ligo-miR microRNA Assay Platform and the PicoSep Single Molecule Analysis Instrument. According to Circulomics CEO Dr. Kelvin Liu, "We see a critical market need for new molecular assays that are not only powerful in nature but also cost effective and easy to use. Winning two such highly competitive awards validates both the novelty of our technologies as well as the new thinking with which we are approaching the market." These new awards were announced in a recent press release.
Circulomics receives coverage on GenomeWeb and Technically Baltimore.